5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3尾 (GSK-3尾) and phosphodiesterase 7 (PDE7) inhibitors: Determination of blood-brain barrier penetration and binding to human serum albumin

详细信息	查看全文 | 推荐本文 |

• 作者：Daniel I. P33 ; rez^a ; ^{dperez@iqm.csic.es} ; Marco Pistolozzi^b ; Valle Palomo^a ; Miriam Redondo^a ; Cecilia Fortugno^b ; Carmen Gil^b ; Guy Felix^c ; Ana Martinez^a ; Carlo Bertucci^b ; ^{carlo.bertucci@unibo.it}
• 关键词：GSK-3 ; glycogen synthase 3 ; PDEs ; phosphodiesterases ; BBB ; blood&ndash ; brain barrier ; HSA ; human serum albumin ; HPLAC ; high-performance liquid affinity chromatography ; CD ; circular dichroism ; PAMPA ; parallel artificial membrane permeability assay ; AD ; Alz
• 刊名：European Journal of Pharmaceutical Sciences
• 出版年：2012
• 期刊代码：15_09280987
• 类别：pha
• 出版时间：11 April, 2012
• 卷：45
• 期：5
• 页码：677-684
• 文件大小：652 K

摘要

5-Imino-1,2,4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3尾 (GSK-3尾) and phosphodiesterase 7 (PDE7) inhibitors were characterized for their ability to pass the blood-brain barrier (BBB) together with their human serum albumin (HSA) binding using high-performance liquid affinity chromatography (HPLAC) and circular dichroism (CD). To study the blood-brain barrier penetration, a parallel artificial membrane permeability assay (PAMPA) using a porcine brain lipid was employed. For the HPLAC investigation, HSA was previously covalently immobilized to the silica matrix of the HPLC column. This HSA-based column was used to characterize the high affinity binding sites of 5-imino-1,2,4-thiadiazoles and quinazolines derivatives to HSA. Displacement experiments in the presence of increasing concentrations of competitors known to bind selectively to the main binding sites of HSA were carried out to determine their possible binding site. The same drug-protein system was studied by CD.

The analysed compounds were able to pass BBB, they present good drug-like properties and they showed a high affinity to HSA. Competition experiments showed an anticooperative interaction at sites I and II, and an independent binding at bilirubin binding site on HSA.